Kala Bio Inc (NASDAQ:KALA)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting -1.80. At the close of trading, the stock’s price was $8.09, to imply an increase of 15.57% or $1.09 in intraday trading. The KALA share’s 52-week high remains $11.20, putting it -38.44% down since that peak but still an impressive 63.91% since price per share fell to its 52-week low of $2.92. The company has a valuation of $52.20M, with an average of 0.21 million shares in intraday trading volume over the past 10 days and average of 107.94K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Kala Bio Inc (KALA), translating to a mean rating of 1.00. Of 4 analyst(s) looking at the stock, 0 analyst(s) give KALA a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 3 recommend it as a Buy.
Kala Bio Inc (NASDAQ:KALA) trade information
After registering a 15.57% upside in the last session, Kala Bio Inc (KALA) has traded red over the past five days. The 5-day price performance for the stock is 40.94%, and 72.13% over 30 days. With these gigs, the year-to-date price performance is 14.27%. Short interest in Kala Bio Inc (NASDAQ:KALA) saw shorts transact 0.32 million shares and set a 2.47 days time to cover.
The extremes give us $7.5 and $7.5 for target low and target high price respectively. As such, KALA has been trading 7.29% off suggested target high and 7.29% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 40.66% for the past 5-year period. While 2025 is set for a 48.31% return in earnings, projections for the next 5 years are at 29.74% annually.
KALA Dividends
Kala Bio Inc has its next earnings report out on 2025-May-14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Kala Bio Inc (NASDAQ:KALA)’s Major holders
Kala Bio Inc insiders hold 1.91% of total outstanding shares, with institutional holders owning 64.18% of the shares at 65.43% float percentage. In total, 64.18% institutions holds shares in the company, led by BAKER BROS. ADVISORS LP. As of 2024-06-30, the company held over 0.89 million shares (or 29.4149% of shares), all amounting to roughly $6.32 million.
The next major institution holding the largest number of shares is SR ONE CAPITAL MANAGEMENT, LP with 0.44 million shares, or about 14.6412% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.15 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Kala Bio Inc (KALA) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 115.44 shares. This is just over 1.79% of the total shares, with a market valuation of $0.93 million. Data from the same date shows that the other fund manager holds a little less at 36.5, or 0.57% of the shares, all valued at about 0.3 million.
